Cargando…
1559O Efficacy and toxicity of BNT162b2 vaccine in cancer patients
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454389/ http://dx.doi.org/10.1016/j.annonc.2021.08.1552 |
| _version_ | 1784570482620628992 |
|---|---|
| author | Ben-Aharon, I. Waldhorn, I. Holland, R. Peer, A. Halberthal, M. Goshen - Lago, T.G. |
| author_facet | Ben-Aharon, I. Waldhorn, I. Holland, R. Peer, A. Halberthal, M. Goshen - Lago, T.G. |
| author_sort | Ben-Aharon, I. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8454389 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84543892021-09-21 1559O Efficacy and toxicity of BNT162b2 vaccine in cancer patients Ben-Aharon, I. Waldhorn, I. Holland, R. Peer, A. Halberthal, M. Goshen - Lago, T.G. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2021-09 2021-09-21 /pmc/articles/PMC8454389/ http://dx.doi.org/10.1016/j.annonc.2021.08.1552 Text en Copyright © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Ben-Aharon, I. Waldhorn, I. Holland, R. Peer, A. Halberthal, M. Goshen - Lago, T.G. 1559O Efficacy and toxicity of BNT162b2 vaccine in cancer patients |
| title | 1559O Efficacy and toxicity of BNT162b2 vaccine in cancer patients |
| title_full | 1559O Efficacy and toxicity of BNT162b2 vaccine in cancer patients |
| title_fullStr | 1559O Efficacy and toxicity of BNT162b2 vaccine in cancer patients |
| title_full_unstemmed | 1559O Efficacy and toxicity of BNT162b2 vaccine in cancer patients |
| title_short | 1559O Efficacy and toxicity of BNT162b2 vaccine in cancer patients |
| title_sort | 1559o efficacy and toxicity of bnt162b2 vaccine in cancer patients |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454389/ http://dx.doi.org/10.1016/j.annonc.2021.08.1552 |
| work_keys_str_mv | AT benaharoni 1559oefficacyandtoxicityofbnt162b2vaccineincancerpatients AT waldhorni 1559oefficacyandtoxicityofbnt162b2vaccineincancerpatients AT hollandr 1559oefficacyandtoxicityofbnt162b2vaccineincancerpatients AT peera 1559oefficacyandtoxicityofbnt162b2vaccineincancerpatients AT halberthalm 1559oefficacyandtoxicityofbnt162b2vaccineincancerpatients AT goshenlagotg 1559oefficacyandtoxicityofbnt162b2vaccineincancerpatients |